Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China flag China · Delayed Price · Currency is CNY
6.05
+0.20 (3.42%)
Jul 3, 2026, 3:04 PM CST
Market Cap3.04B -2.3%
Revenue (ttm)1.03B +1.3%
Net Income225.27M +30.0%
EPS0.45 +29.9%
Shares Out 503.20M
PE Ratio13.52
Forward PEn/a
Dividend0.30 (5.13%)
Ex-Dividend DateJun 16, 2026
Volume11,597,957
Open5.65
Previous Close5.85
Day's Range5.65 - 6.07
52-Week Range5.32 - 8.60
Beta0.35
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China. [Read more]

Sector Healthcare
Founded 1998
Employees 2,108
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002412
Full Company Profile

Financial Performance

In 2025, SHE:002412's revenue was 1.04 billion, an increase of 3.41% compared to the previous year's 1.00 billion. Earnings were 198.12 million, a decrease of -10.05%.

Financial Statements